BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiao LL, Wu XX, Chen JJ, Yan D, Shi DY, Huang JR, Xu XW, Li LJ. Progress in hepatitis B virus-related acute-on-chronic liver failure treatment in China: A large, multicenter, retrospective cohort study using a propensity score matching analysis. Hepatobiliary Pancreat Dis Int 2021;20:535-41. [PMID: 34303609 DOI: 10.1016/j.hbpd.2021.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Yuan M, Yao L, Hu X, Jiang Y, Li L. Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies. Front Genet 2022;13:1004912. [DOI: 10.3389/fgene.2022.1004912] [Reference Citation Analysis]
2 Zhang L, Hu J, Gou C, Jin H, Zhang C, Liu Y, Wang Y, Wang X, Yokota S. Serum Interleukins as Potential Prognostic Biomarkers in HBV-Related Acute-on-Chronic Liver Failure. Mediators of Inflammation 2022;2022:1-13. [DOI: 10.1155/2022/7794890] [Reference Citation Analysis]
3 Zhang H, Xian J, Li Y, Xiao L, Wang L. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2022;2022:1889628. [PMID: 35815265 DOI: 10.1155/2022/1889628] [Reference Citation Analysis]
4 Cui D, Li W, Jiang D, Wu J, Xie J, Wu Y. Advances in Multi-Omics Applications in HBV-Associated Hepatocellular Carcinoma. Front Med (Lausanne) 2021;8:754709. [PMID: 34660653 DOI: 10.3389/fmed.2021.754709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]